Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
15000 participants
OBSERVATIONAL
2011-06-30
2019-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Development of a Prenatal Test for Fetal Aneuploidy Detection
NCT01451671
Non-invasive Prenatal Diagnostic Validation Study
NCT01574781
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
NCT00971334
National Prevalence and Impact of Noninvasive Prenatal Testing
NCT02284399
Cell Based Non Invasive Prenatal Testing as an Alternative to Chorionic Villus Sampling Following Preimplantation Genetic Testing
NCT04584047
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Subject is able to provide informed consent
* Subject is ≥ 18 years of age
* Subject is at least 10 weeks gestation for general enrollment
* Subject has no known risk factors for chromosomal abnormalities of the fetus
* Subject has no suspected or confirmed fetal abnormalities
Exclusion Criteria
* Subject is unwilling to undergo a blood draw
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cindy Cisneros
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Cindy Cisneros
CRA
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Tracy Roberts
Role: STUDY_DIRECTOR
Ariosa Diagnostics
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ariosa Diagnostics
San Jose, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
TD003
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.